BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study
Open Access
- 16 May 2023
- journal article
- research article
- Published by Elsevier in The Lancet Child & Adolescent Health
- Vol. 7 (7) , 463-470
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
This publication has 16 references indexed in Scilit:
- Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design studyClinical Microbiology and Infection, 2022
- Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5The Lancet Microbe, 2022
- Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of AgeNew England Journal of Medicine, 2022
- Effects of Previous Infection and Vaccination on Symptomatic Omicron InfectionsNew England Journal of Medicine, 2022
- Mind the “Vaccine Fatigue”Frontiers in Immunology, 2022
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) VariantNew England Journal of Medicine, 2022
- Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsScience Immunology, 2022
- Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19New England Journal of Medicine, 2022
- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionNew England Journal of Medicine, 2022
- Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in FranceThe Lancet Healthy Longevity, 2021